Wegovy vs Mounjaro: The Complete Clinical Comparison
Understanding the Wegovy Equivalent to Mounjaro 10mg Dosing
When comparing Wegovy vs Mounjaro, the most common question centres around dose equivalency, particularly the Wegovy equivalent to Mounjaro 10mg. However, direct dose comparisons can be misleading due to fundamental differences in their active ingredients and mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist. The dual mechanism means Mounjaro's dosing schedule operates differently from Wegovy's linear escalation pattern.
Wegovy follows a structured 5-dose escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance. Mounjaro's 6-dose schedule includes 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg options. Rather than seeking a direct Wegovy equivalent to Mounjaro 10mg, patients should focus on therapeutic equivalency determined by their prescriber based on individual response and tolerability. Both treatments require careful dose escalation to minimise gastrointestinal side effects whilst optimising weight management outcomes.
Pricing Comparison: Wegovy vs Mounjaro Investment
EverydayMeds offers competitive pricing for both treatments, with Wegovy starting at £79.99 for the 0.25mg starter dose and Mounjaro beginning at £89.99 for 2.5mg. New customers benefit from discount code FIRST40, whilst returning customers can use DOSE25 at checkout. The cost progression reflects each medication's escalation schedule, with Wegovy's maintenance dose (2.4mg) priced at £209.99 compared to Mounjaro 10mg at £179.99. Bundle options provide convenient multi-month supplies, such as the Wegovy Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99.
When evaluating long-term investment in weight management, both treatments represent similar monthly costs during maintenance phases. The choice between seeking a Wegovy equivalent to Mounjaro 10mg should consider individual response patterns rather than purely cost considerations. Our clinical team can provide personalised recommendations during your assessment, ensuring optimal value alongside therapeutic outcomes. Express prescriber review is available within 24 hours for both medications, with standard review completed within 3 working days.
Clinical Evidence: STEP vs SURMOUNT Trial Results
Wegovy's efficacy is demonstrated through the comprehensive STEP trial programme, with STEP 1 showing approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions. The SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management. These results establish semaglutide as a cornerstone therapy for patients seeking sustainable weight loss alongside reduced-calorie diet and increased physical activity.
Mounjaro's evidence base centres on the SURMOUNT trials, demonstrating the dual GIP/GLP-1 mechanism's potential benefits. However, direct comparison of trial percentages between Wegovy and Mounjaro wouldn't provide meaningful insights due to different study designs, populations, and endpoints. Instead, both treatments have shown substantial efficacy in their respective clinical programmes, supporting their positions as prescription-only medicines for weight management in appropriate patients.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones released after eating. This mechanism works primarily in the brain's appetite centres, reducing hunger signals and promoting feelings of fullness after smaller meals. The treatment may help reduce food cravings and slow gastric emptying, creating a natural reduction in caloric intake when combined with dietary modifications. Semaglutide's once-weekly dosing provides consistent appetite regulation throughout the week, supporting sustainable lifestyle changes rather than gradual weight management approaches. The GLP-1 mechanism has been extensively studied, with over a decade of clinical experience in diabetes management before adaptation for weight management applications.
EverydayMeds Ordering Process: Simple and Secure
Obtaining either Wegovy or Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to evaluate your suitability for prescription-only weight management medication. Our UK-registered prescribers (GPhC #9012878) review every application thoroughly, with standard review completed within 3 working days or express 24-hour service available. Once approved, your medication is dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. All deliveries are trackable and require signature confirmation, ensuring secure receipt of your prescription medication. Our clinical team remains available throughout your treatment journey, providing ongoing support and monitoring as you progress through your chosen medication's dose escalation schedule.
Storage and Practical Considerations
Storage requirements present a notable practical difference when comparing Wegovy vs Mounjaro, particularly for patients with active lifestyles or frequent travel. Wegovy maintains stability for up to 6 weeks at room temperature (below 30°C) once removed from refrigerated storage, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigerated storage at 2-8°C before first use, but Wegovy's extended room temperature stability offers greater flexibility for holidays, business travel, or emergency situations. The FlexTouch pen delivery system used by Wegovy provides intuitive dose administration with clear dose confirmation, whilst Mounjaro utilises similar pen technology with comparable ease of use. Both treatments require proper disposal of needles and pens according to local pharmaceutical waste guidelines provided with every delivery.
Choosing Between Wegovy and Mounjaro 10mg: Personalised Approach
Rather than seeking a direct Wegovy equivalent to Mounjaro 10mg, patients benefit from understanding each treatment's unique characteristics and how they align with individual circumstances. Wegovy's established GLP-1 mechanism provides predictable appetite regulation with extensive long-term safety data, whilst Mounjaro's dual receptor approach offers a novel mechanism that may suit patients who haven't responded optimally to single-hormone therapies. Factors including previous medication responses, lifestyle requirements, and specific health goals should guide treatment selection rather than dose comparisons alone.
Both treatments are available through EverydayMeds with identical clinical assessment standards and delivery procedures, ensuring patients receive appropriate care regardless of their chosen medication. Our prescribers can provide detailed guidance on expected timelines, potential side effects, and realistic outcome expectations during the assessment process. The decision between Wegovy and Mounjaro represents a collaborative choice between patient and prescriber, based on clinical evidence rather than marketing claims or simplified dose equivalencies.
Start Your Weight Management Journey Today
Both Wegovy and Mounjaro are immediately available through EverydayMeds, with comprehensive clinical support from our GPhC-registered team (#9012878) throughout your treatment journey. New customers can apply discount code FIRST40 at checkout, whilst returning customers benefit from code DOSE25 for continued savings. Rather than focusing solely on finding a Wegovy equivalent to Mounjaro 10mg, we encourage patients to complete our clinical assessment to receive personalised recommendations based on individual medical history and treatment goals. Express prescriber review ensures you can begin treatment within 24 hours of assessment completion, with next-day cold-chain delivery maintaining medication quality and potency. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your confidential assessment and take the first step towards sustainable weight management with expert clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
